Barely Significant
← all excerpts

Safety and efficacy of apixaban versus enoxaparin in gynecologic cancer patients undergoing open surgery: an open-label randomized controlled trial.

Thromb J · 2026 · PMC13011513 · PMID 41872895

1
hedged sentence
closest p
boldest claim

The sentences

showed a trendno p-value reported
Although non-significant, their safety data showed a trend toward greater safety with apixaban.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.